Shares of Cellebrite (CLBT), a leader in digital investigative solutions, surged 19.29% in pre-market trading on Thursday, following the release of its impressive third-quarter 2025 financial results and an optimistic future outlook.

The company reported Q3 revenue of $126.03 million, surpassing analyst expectations of $122.01 million and marking an 18% year-over-year increase. Cellebrite's adjusted EBITDA of $37.74 million also outperformed expectations, coming in significantly higher than the projected $32.18 million. This strong performance resulted in an adjusted EBITDA margin of 29.9%, showcasing the company's operational efficiency.

Key drivers of Cellebrite's success included a 21% growth in subscription revenue, fueled by strong demand in U.S. state and local markets, as well as in Latin America. CEO Thomas E. Hogan highlighted significant expansion within the U.S. Federal business segment, which contributed to the overall growth. The company also announced its Autumn 2025 Release, introducing new capabilities and integrations that enhance its Digital Investigation Platform, further solidifying its market position. Looking ahead, Cellebrite raised its full-year 2025 revenue guidance to between $470 million and $475 million, representing a 17% to 18% annual growth. This optimistic outlook, coupled with the strong Q3 results, has instilled confidence in investors, driving the substantial pre-market stock price increase.